Media headlines about HCP (NYSE:HCP) have been trending somewhat positive recently, according to Accern. Accern identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. HCP earned a coverage optimism score of 0.12 on Accern’s scale. Accern also gave media coverage about the real estate investment trust an impact score of 46.4328924962372 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
Here are some of the headlines that may have effected Accern Sentiment Analysis’s rankings:
- Anticipated $0.47 EPS for HCP, Inc. (HCP) on May, 1 (thecasualsmart.com)
- Security Capital Research & Management Increased By $161.48 Million Its Hcp (HCP) Stake; Litespeed Management … (mtastar.com)
- 15:00 Allingtons Kia Official Car Sponsors Handicap Chase2m 4f 19y (skysports.com)
- HCP (HCP) Downgraded to “Sell” at BidaskClub (americanbankingnews.com)
- Do SMAs Signal a Trend Reversal? – HCP Inc (NYSE: HCP) (stockspen.com)
Shares of NYSE HCP traded up $0.18 during mid-day trading on Friday, hitting $22.42. The company had a trading volume of 1,937,007 shares, compared to its average volume of 4,093,043. The company has a market cap of $10,440.42, a price-to-earnings ratio of 11.50, a price-to-earnings-growth ratio of 5.48 and a beta of 0.26. HCP has a 12 month low of $21.48 and a 12 month high of $33.67. The company has a current ratio of 0.31, a quick ratio of 0.31 and a debt-to-equity ratio of 1.23.
A number of brokerages have weighed in on HCP. UBS restated a “sell” rating and set a $21.00 price objective (down previously from $25.00) on shares of HCP in a research note on Wednesday, February 21st. ValuEngine downgraded HCP from a “buy” rating to a “hold” rating in a report on Friday, February 2nd. Jefferies Group reaffirmed a “hold” rating and set a $26.00 target price on shares of HCP in a report on Tuesday, February 13th. Robert W. Baird set a $24.00 target price on HCP and gave the stock a “hold” rating in a report on Thursday, February 15th. Finally, BMO Capital Markets set a $25.00 target price on HCP and gave the stock a “hold” rating in a report on Tuesday, February 13th. Three analysts have rated the stock with a sell rating, eleven have assigned a hold rating and five have given a buy rating to the company’s stock. HCP presently has a consensus rating of “Hold” and an average target price of $27.50.
In related news, insider Kendall K. Young purchased 14,000 shares of the business’s stock in a transaction that occurred on Wednesday, February 14th. The shares were acquired at an average price of $21.91 per share, with a total value of $306,740.00. Following the acquisition, the insider now owns 48,544 shares in the company, valued at approximately $1,063,599.04. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Company insiders own 0.14% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Somewhat Positive News Coverage Somewhat Unlikely to Impact HCP (HCP) Share Price” was first published by Week Herald and is owned by of Week Herald. If you are reading this article on another publication, it was stolen and republished in violation of United States and international copyright & trademark legislation. The legal version of this article can be accessed at https://weekherald.com/2018/04/15/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-hcp-hcp-share-price.html.
HCP Company Profile
HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.